🍽🦠 PubMed Studies Citing Bacteria Shifts for Saccharomyces cerevisiae var boulardii {S. boulardii} - Faecalibacterium prausnitzii

Citations are updated once a week. Recently added citations may not appear.

5 Citations Found, Full List Requires Login Summary Publisher Link Html Article Download Article Why do I only have some/no links buttons showing?
πŸ““ - Direct Citation   |   πŸ‘ͺ - Infer Parent  |   πŸ‘Ά - Infer Child |   βš—οΈ - Inferred from bacteria association
For Samples: 😁 - Shifts in right direction   |   😒 - Shifts in wrong direction
Context Citation
Saccharomyces cerevisiae var boulardii {S. boulardii} - Faecalibacterium prausnitzii    👶 Comparison of the Effects of Enzymolysis Seaweed Powder and Saccharomyces boulardii on Intestinal Health and Microbiota Composition in Kittens.
Metabolites (Metabolites ) Vol: 13 Issue 5 Pages:
Pub: 2023 May 8 Epub: 2023 May 8 Authors Zhang M , Mo R , Li M , Qu Y , Wang H , Liu T , Liu P , Wu Y ,
Html Article Publication
Saccharomyces cerevisiae var boulardii {S. boulardii} - Faecalibacterium prausnitzii    📓 Impact of Saccharomyces boulardii CNCM I-745 on Bacterial Overgrowth and Composition of Intestinal Microbiota in Diarrhea-Predominant Irritable Bowel Syndrome Patients: Results of a Randomized Pilot Study.
Digestive diseases (Basel, Switzerland) (Dig Dis ) Vol: 41 Issue 5 Pages: 798-809
Pub: 2023 Epub: 2023 Jan 11 Authors Bustos Fernández LM , Man F , Lasa JS ,
Publication
Saccharomyces cerevisiae var boulardii {S. boulardii} - Faecalibacterium prausnitzii    📓 [Functional biostructure of colonic microbiota (central fermenting area, germinal stock area and separating mucus layer) in healthy subjects and patients with diarrhea treated with Saccharomyces boulardii].
Gastroenterologie clinique et biologique (Gastroenterol Clin Biol ) Vol: 34 Suppl 1 Issue Pages: S79-92
Pub: 2010 Sep Epub: Authors Swidsinski A , Loening-Baucke V , Kirsch S , Doerffel Y ,
Publication
Saccharomyces cerevisiae var boulardii {S. boulardii} - Faecalibacterium prausnitzii    📓 Dietary Saccharomyces cerevisiae boulardii CNCM I-1079 Positively Affects Performance and Intestinal Ecosystem in Broilers during a Campylobacter jejuni Infection.
Microorganisms (Microorganisms ) Vol: 7 Issue 12 Pages:
Pub: 2019 Nov 21 Epub: 2019 Nov 21 Authors Massacci FR , Lovito C , Tofani S , Tentellini M , Genovese DA , De Leo AAP , Papa P , Magistrali CF , Manuali E , Trabalza-Marinucci M , Moscati L , Forte C ,
Publication
Saccharomyces cerevisiae var boulardii {S. boulardii} - Faecalibacterium prausnitzii    📓 Early supplementation of Saccharomyces cerevisiae boulardii CNCM I-1079 in newborn dairy calves increases IgA production in the intestine at 1 week of age.
Journal of dairy science (J Dairy Sci ) Vol: 103 Issue 9 Pages: 8615-8628
Pub: 2020 Sep Epub: 2020 Jul 16 Authors Villot C , Chen Y , Pedgerachny K , Chaucheyras-Durand F , Chevaux E , Skidmore A , Guan LL , Steele MA ,
Publication

BOOM

All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.

Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)